We are live on
!
Find out more
HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
41.95%
This Fund
S&P 500
This Quarter
Est. Return
+21.43%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$3.5B
AUM Growth
+$531M
(+18%)
Cap. Flow
+$136M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
16.73%
Holding
1,018
New
90
Increased
485
Reduced
375
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$43.2M |
| 2 |
AIVC
Amplify Bloomberg AI Equal Weight ETF
AIVC
|
+$20.8M |
| 3 |
Avantis International Equity ETF
AVDE
|
+$18.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.2M |
| 5 |
Invesco S&P International Developed Momentum ETF
IDMO
|
+$7.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$40.2M |
| 2 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$34M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$22.1M |
| 4 |
Celcuity
CELC
|
+$9.49M |
| 5 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$7.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.5% |
| 2 | Technology | 14.69% |
| 3 | Healthcare | 10.37% |
| 4 | Industrials | 9.1% |
| 5 | Financials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
TRI-Continental Corp
TY
$1.9B
| $5.39M | 0.15% |
156,550
+11,778
| +8% | +$404K |
|
177
Mercury Systems
MRCY
$4.96B
| $5.37M | 0.15% |
43,902
+4,457
| +11% | +$425K |
|
178
Amphenol
APH
$204B
| $5.37M | 0.15% |
60,900
+2,958
| +5% | +$213K |
|
179
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$640M
| $5.36M | 0.15% |
427,631
+77,419
| +22% | +$958K |
|
180
A10 Networks
ATEN
$1.79B
| $5.3M | 0.15% |
141,978
+27,882
| +24% | +$810K |
|
|
SCHW
181
Charles Schwab
SCHW
$189B
| $5.3M | 0.15% |
57,465
+1,441
| +3% | +$131K |
|
182
American Express
AXP
$220B
| $5.28M | 0.15% |
15,600
+648
| +4% | +$207K |
|
183
Olema Pharmaceuticals
OLMA
$941M
| $5.26M | 0.15% |
420,211
-61,274
| -13% | -$821K |
|
184
NiSource
NI
$19.8B
| $5.21M | 0.15% |
109,511
-271
| -0.2% | -$12.8K |
|
185
State Street SPDR S&P 500 ETF Trust
SPY
$814B
| $5.19M | 0.15% |
6,948
+165
| +2% | +$120K |
|
186
Pacira BioSciences
PCRX
$1.05B
| $5.16M | 0.15% |
203,520
+48,124
| +31% | +$1.14M |
|
187
DTE Energy
DTE
$28.3B
| $5.14M | 0.15% |
33,731
+4,308
| +15% | +$629K |
|
188
Nasdaq
NDAQ
$54.2B
| $5.11M | 0.15% |
64,865
-4,823
| -7% | -$423K |
|
189
Cogent Biosciences
COGT
$6.03B
| $5.1M | 0.15% |
131,775
-194,697
| -60% | -$6.81M |
|
190
Raymond James Financial
RJF
$34.3B
| $4.93M | 0.14% |
32,432
+1,955
| +6% | +$297K |
|
191
TAT Technologies
TATT
$520M
| $4.86M | 0.14% |
100,864
+8,095
| +9% | +$325K |
|
|
PCQ
192
Pimco California Municipal Income Fund
PCQ
$162M
| $4.83M | 0.14% |
538,721
-151,763
| -22% | -$1.33M |
|
193
Chevron
CVX
$409B
| $4.83M | 0.14% |
29,152
-735
| -2% | -$137K |
|
194
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
| $4.77M | 0.14% |
315,801
+28,418
| +10% | +$431K |
|
195
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$343M
| $4.74M | 0.14% |
254,177
+43,598
| +21% | +$772K |
|
196
Xcel Energy
XEL
$47.3B
| $4.7M | 0.13% |
58,481
+3,787
| +7% | +$302K |
|
197
Qualcomm
QCOM
$180B
| $4.68M | 0.13% |
25,330
-3,019
| -11% | -$565K |
|
198
Madrigal Pharmaceuticals
MDGL
$12.5B
| $4.66M | 0.13% |
8,684
+68
| +0.8% | +$34.8K |
|
199
Immunovant
IMVT
$8.11B
| $4.65M | 0.13% |
120,686
+29,677
| +33% | +$904K |
|
200
BWX Technologies
BWXT
$14.4B
| $4.64M | 0.13% |
23,822
+815
| +4% | +$170K |
|
Similar funds
DCM
CWS
RA
CCM
CK
SYBT
NBS
FFM
Hennion & Walsh Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Hennion & Walsh Asset Management held 1,018 positions worth $3.5B, up 18% from $2.97B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Hennion & Walsh Asset Management deployed $136M of net new capital in Q2 2026, opening 90 new positions and adding to 485 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 664,010 shares worth $45.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $40.2M trimmed.
- Hennion & Walsh Asset Management's largest Q2 2026 buy was BlackRock US Equity Factor Rotation ETF: 664,010 shares worth $45.2M.
- Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $10.2M increase.
- Hennion & Walsh Asset Management's biggest Q2 2026 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $40.2M.
- Hennion & Walsh Asset Management fully exited Invesco S&P 500 Equal Weight ETF in Q2 2026, selling an estimated $22.1M.
- Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $3.5B portfolio in Q2 2026.
- Hennion & Walsh Asset Management opened 90 new positions and closed 63 in Q2 2026.
- Hennion & Walsh Asset Management's portfolio value rose 18% quarter-over-quarter to $3.5B.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.